Relevance and feasibility of principles for health and environmental risk decision-making

References

• Adebisi, Y. A 2023. “Balancing the Risks and Benefits of Antibiotic Use in a Globalized World: The Ethics of Antimicrobial Resistance.” Globalization and Health 19 (1): 27. https://doi.org/10.1186/s12992-023-00930-z
   PubMed Web of Science ®Google Scholar
• Allen, M, D. Schaleben-Boateng, C. Davey, M. Hang, and S. Pergament. 2015. “Concept Mapping as an Approach to Facilitate Participatory Intervention Building.” Progress in Community Health Partnerships: Research, Education, and Action 9 (4): 599–608. https://doi.org/10.1353/cpr.2015.0076
   PubMedGoogle Scholar
• Anderson, M, K. Schulze, A. Cassini, D. Plachouras, and E. Mossialos. 2019. “A Governance Framework for Development and Assessment of National Action Plans on Antimicrobial Resistance.” The Lancet Infectious Diseases 19 (11): e371–e384. https://doi.org/10.1016/S1473-3099(19)30415-3
   PubMed Web of Science ®Google Scholar
• Antimicrobial Resistance Collaborators. 2022. “Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis.” The Lancet 399 (10325): 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0.
   PubMed Web of Science ®Google Scholar
• APVMA (Australian Pesticides and Veterinary Medicines Authority). 2019. Risk Assessment Manuals. Accessed May 17, 2019. https://apvma.gov.au/node/45561
   Google Scholar
• Balkhy, H. H, H. M. Zowawi, M. M. Alshamrani, B. Allegranzi, A. Srinivasan, H. M. Al-Abdely, A. M. Somily, and M. A. Al-Quwaizani. 2018. “Antimicrobial Resistance: A Round Table Discussion on the “One Health” Concept from the Gulf Cooperation Council Countries. Part Two: A Focus on Human Health.” Journal of Infection and Public Health 11 (6): 778–783. https://doi.org/10.1016/j.jiph.2018.05.008
   PubMed Web of Science ®Google Scholar
• Berman, T. S, Z. Barnett-Itzhaki, T. Berman, and E. Marom. 2023. “Antimicrobial Resistance in Food-Producing Animals: Towards Implementing a One Health Based National Action Plan in Israel.” Israel Journal of Health Policy Research 12 (1): 18. https://doi.org/10.1186/s13584-023-00562-z
   PubMed Web of Science ®Google Scholar
• Bhuller, Y, D. Ramsingh, M. Beal, S. Kulkarni, M. Gagne, and T. S. Barton-Maclaren. 2021. “Canadian Regulatory Perspective on Next Generation Risk Assessments for Pest Control Products and Industrial Chemicals.” Frontiers in Toxicology 3:748406. https://doi.org/10.3389/ftox.2021.748406
   PubMedGoogle Scholar
• Bhuller, Y, and C. C. Trevithick-Sutton. 2024. “Risk Communication: Lessons from an Ethnographic, Pragmatic, and Canadian Regulatory Perspective.” Frontiers in Communication 9. https://doi.org/10.3389/fcomm.2024.1235055
   Google Scholar
• Bury, D, C. Alexander-White, H. J. Clewell 3rd, M. Cronin, B. Desprez, A. Detroyer, A. Efremenko, et al. 2021. “New Framework for a Non-Animal Approach Adequately Assures the Safety of Cosmetic Ingredients - a Case Study on Caffeine.” Regulatory Toxicology and Pharmacology: RTP 123:104931. https://doi.org/10.1016/j.yrtph.2021.104931
   PubMed Web of Science ®Google Scholar
• Canadian Institutes of Health Research. 2012. Guide to Knowledge Translation Planning at CIHR: Integrated and End-Of-Grant Approaches. Accessed November 30, 2021. https://cihr-irsc.gc.ca/e/documents/kt_lm_ktplan-en.pdf
   Google Scholar
• Chandra, P, U. Mk, V. Ke, C. Mukhopadhyay, D. A. U, S. R. M, and R. V. 2021. “Antimicrobial Resistance and the Post Antibiotic Era: Better Late Than Never Effort.” Expert opinion on drug safety 20 (11): 1375–1390. https://doi.org/10.1080/14740338.2021.1928633
   PubMed Web of Science ®Google Scholar
• Chuenkitmongkol, S, R. Solante, E. Burhan, S. Chariyalertsak, N. C. Chiu, D. Do-Van, M. Husin, et al. 2022. “Expert Review on Global Real-World Vaccine Effectiveness Against SARS-CoV-2.” Expert Review of Vaccines 21 (9): 1255–1268. https://doi.org/10.1080/14760584.2022.2092472
   PubMed Web of Science ®Google Scholar
• Clippinger, A. J, T. Henry, C. Stedeford, T. Hirn, A. Stucki, and C. Terry. 2022. “Chemical Testing Using New Approach Methodologies (NAMs).” Front Toxicol 4:1048900. https://doi.org/10.3389/ftox.2022.1048900
   PubMedGoogle Scholar
• Clippinger, A. J, H. A. Raabe, D. G. Allen, N. Y. Choksi, A. J. van der Zalm, N. C. Kleinstreuer, J. Barroso, and A. B. Lowit. 2021. “Human-Relevant Approaches to Assess Eye Corrosion/Irritation Potential of Agrochemical Formulations.” Cutaneous and ocular toxicology 40 (2): 145–167. https://doi.org/10.1080/15569527.2021.1910291
   PubMed Web of Science ®Google Scholar
• Cote, I, P. T. Anastas, L. S. Birnbaum, R. M. Clark, D. J. Dix, S. W. Edwards, and P. W. Preuss. 2012. “Advancing the Next Generation of Health Risk Assessment.” Environmental Health Perspectives 120 (11): 1499–1502. https://doi.org/10.1289/ehp.1104870
   PubMed Web of Science ®Google Scholar
• Cote, I, M. E. Andersen, G. T. Ankley, S. Barone, L. S. Birnbaum, K. Boekelheide, F. Y. Bois, et al. 2016. “The Next Generation of Risk Assessment Multi-Year Study—Highlights of Findings, Applications to Risk Assessment, and Future Directions.” Environmental Health Perspectives 124 (11): 1671–1682. https://doi.org/10.1289/EHP233
   PubMed Web of Science ®Google Scholar
• Council of Canadian Academies. 2012. Integrating Emerging Technologies into Chemical Safety Assessment - the Expert Panel on the Integrated Testing of Pesticides. https://cca-reports.ca/reports/integrating-emerging-technologies-into-chemical-safety-assessment/
   Google Scholar
• Creswell, J. W, and V. L. P. Clark. 2018. Designing and Conducting Mixed Methods Research. Third Edition ed. Thousand Oaks, California: SAGE Publications, Inc.
   Google Scholar
• Dent, M, R. T. Amaral, P. A. Da Silva, J. Ansell, F. Boisleve, M. Hatao, A. Hirose, et al. 2018. “Principles Underpinning the Use of New Methodologies in the Risk Assessment of Cosmetic Ingredients.” Computational Toxicology 7:20–26. https://doi.org/10.1016/j.comtox.2018.06.001
   Google Scholar
• EFSA (European Food Safety Authority). 2024. Cross-Cutting Guidance. Accessed May 17, 2024. https://efsa.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1831-4732.GUIDANCE
   Google Scholar
• Environment and Climate Change Canada. (2023a). Bill S-5: Strengthening Environmental Protection for a Healthier Canada Act. Accessed July 5, 2023. https://www.canada.ca/en/environment-climate-change/news/2023/06/bill-s-5-strengthening-environmental-protection-for-a-healthier-canada-act.html.
   Google Scholar
• Environment and Climate Change Canada. 2023b. News Release: Stronger Chemicals Management and the Right to a Healthy Environment: Canada’s Cornerstone Environmental Law Has Been Modernized. Accessed July 5, 2023. https://www.canada.ca/en/environment-climate-change/news/2023/06/stronger-chemicals-management-and-the-right-to-a-healthy-environment-canadas-cornerstone-environmental-law-has-been-modernized.html.
   Google Scholar
• EPA (U.S. Environmental Protection Agency). 2014. Framework for Human Health Risk Assessment to Inform Decision Making. https://www.epa.gov/sites/default/files/2014-12/documents/hhra-framework-final-2014.pdf
   Google Scholar
• Essack, S. Y, A. T. Desta, R. E. Abotsi, and E. E. Agoba. 2017. “Antimicrobial Resistance in the WHO African Region: Current Status and Roadmap for Action.” Journal Public Health (Oxf) 39:8–13. https://doi.org/10.1093/pubmed/fdw015
   PubMed Web of Science ®Google Scholar
• FDA (U.S. Food & Drug Administration). 2024. FDA Guidance Documents. Accessed May 17, 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents
   Google Scholar
• Fentem, J. H 2023. “The 19th FRAME Annual Lecture, November 2022: Safer Chemicals and Sustainable Innovation Will Be Achieved by Regulatory Use of Modern Safety Science, Not by More Animal Testing.” Alternatives to Laboratory Animals: ATLA 51 (2): 90–101. https://doi.org/10.1177/02611929231158236
   PubMed Web of Science ®Google Scholar
• Fentem, J, I. Malcomber, G. Maxwell, and C. Westmoreland. 2021. “Upholding the Eu’s Commitment to ‘Animal Testing As a Last Resort’ Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety Science.” Alternatives to Laboratory Animals: ATLA 49 (4): 122–132. https://doi.org/10.1177/02611929211040824
   PubMed Web of Science ®Google Scholar
• Foth, H, and A. W. Hayes. 2008. “Background of REACH in EU Regulations on Evaluation of Chemicals.” Human and Experimental Toxicology 27 (6): 443–461. https://doi.org/10.1177/0960327108092296
   PubMed Web of Science ®Google Scholar
• Gilmour, N, J. Reynolds, K. Przybylak, M. Aleksic, N. Aptula, M. T. Baltazar, R. Cubberley, et al. 2022. “Next Generation Risk Assessment for Skin Allergy: Decision Making Using New Approach Methodologies.” Regulatory Toxicology and Pharmacology: RTP 131:105159. https://doi.org/10.1016/j.yrtph.2022.105159
   PubMed Web of Science ®Google Scholar
• Goodman, J. E, C. P. Boyce, D. M. Pizzurro, and L. R. Rhomberg. 2014. “Strengthening the Foundation of Next Generation Risk Assessment.” Regulatory Toxicology and Pharmacology: RTP 68 (1): 160–170. https://doi.org/10.1016/j.yrtph.2013.12.002
   PubMed Web of Science ®Google Scholar
• Government of Canada. 2014. About Health Canada. Accessed January 9, 2014. https://www.canada.ca/en/health-canada/corporate/about-health-canada.html
   Google Scholar
• Government of Canada. 2020. Publications - Health. Accessed May 17. https://www.canada.ca/en/services/health/publications.html.
   Google Scholar
• Government of Canada. 2022a. COVID-19 mRNA Vaccines. Health Canada. Accessed January 10, 2022a. https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/type-mrna.html
   Google Scholar
• Government of Canada. 2022b. Drug and Vaccine Authorizations for COVID-19: Overview. Health Canada. Accessed January 10, 2022b. https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization.html
   Google Scholar
• Government of Canada. 2024a. Pest Control Products Act. Accessed March 10. https://laws.justice.gc.ca/eng/acts/P-9.01/page-1.html.
   Google Scholar
• Government of Canada. 2024b. Strengthening Environmental Protection for a Healthier Canada Act Accessed March 10. https://laws-lois.justice.gc.ca/eng/AnnualStatutes/2023_12/.
   Google Scholar
• Greenhalgh, T, G. Wong, J. Jagosh, J. Greenhalgh, A. Manzano, G. Westhorp, and R. Pawson. 2015. “Protocol—The RAMESES II Study: Developing Guidance and Reporting Standards for Realist Evaluation: Figure 1.” British Medical Journal Open 5 (8): e008567. https://doi.org/10.1136/bmjopen-2015-008567
   PubMed Web of Science ®Google Scholar
• Gross, L, and L. S. Birnbaum. 2017. “Regulating Toxic Chemicals for Public and Environmental Health.” PLOS Biology 15 (12): e2004814. https://doi.org/10.1371/journal.pbio.2004814
   PubMed Web of Science ®Google Scholar
• Health, Canada. 2000. Health Canada Decision-Making Framework for Identifying, Assessing, and Managing Health Risks. Canada. https://www.canada.ca/en/health-canada/corporate/about-health-canada/reports-publications/health-products-food-branch/health-canada-decision-making-framework-identifying-assessing-managing-health-risks.html
   Google Scholar
• Health Canada. 2011. About Mission, Values, Activities. Accessed June 22, 2023. https://www.canada.ca/en/health-canada/corporate/about-health-canada/activities-responsibilities/mission-values-activities.html
   Google Scholar
• Health Canada. 2017. Knowledge Translation Planner. Canada. https://www.canada.ca/en/health-canada/corporate/about-health-canada/reports-publications/grants-contributions/knowledge-transfer-planner.html
   Google Scholar
• Herrmann, K, F. Pistollato, and M. L. Stephens. 2019. “Beyond the 3Rs: Expanding the Use of Human-Relevant Replacement Methods in Biomedical Research.” ALTEX 36:343–352. https://doi.org/10.14573/altex.1907031
   PubMedGoogle Scholar
• Hilton, G. M, C. Adcock, G. Akerman, J. Baldassari, M. Battalora, W. Casey, A. J. Clippinger, et al. 2022. “Rethinking Chronic Toxicity and Carcinogenicity Assessment for Agrochemicals Project (ReCAAP): A Reporting Framework to Support a Weight of Evidence Safety Assessment without Long-Term Rodent Bioassays.” Regulatory Toxicology and Pharmacology: RTP 131:105160. https://doi.org/10.1016/j.yrtph.2022.105160
   PubMed Web of Science ®Google Scholar
• Hilton, G. M, Y. Bhuller, J. E. Doe, D. C. Wolf, and R. A. Currie. 2023. “A New Paradigm for Regulatory Sciences.” Regulatory Toxicology and Pharmacology: RTP 145:105524. https://doi.org/10.1016/j.yrtph.2023.105524
   PubMed Web of Science ®Google Scholar
• Honda, H, T. Goto, Y. Uehara, and A. Takamatsu. 2023. “Promotion of Antimicrobial Stewardship Following Issuance of the Antimicrobial Resistance National Action Plan in Japan: A Systematic Review of 2016–2020.” International Journal of Antimicrobial Agents 62 (1): 106829. https://doi.org/10.1016/j.ijantimicag.2023.106829
   PubMed Web of Science ®Google Scholar
• ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods). 2018. A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States. https://ntp.niehs.nih.gov/whatwestudy/niceatm/natl-strategy
   Google Scholar
• Iwu, C. D, and S. M. Patrick. 2021. “An Insight into the Implementation of the Global Action Plan on Antimicrobial Resistance in the WHO African Region: A Roadmap for Action.” International Journal of Antimicrobial Agents 58 (4): 106411. https://doi.org/10.1016/j.ijantimicag.2021.106411
   PubMed Web of Science ®Google Scholar
• Kakkar, M, P. Chatterjee, A. S. Chauhan, D. Grace, J. Lindahl, A. Beeche, F. Jing, and S. Chotinan. 2018. “Antimicrobial Resistance in South East Asia: Time to Ask the Right Questions.” Global Health Action 11 (1): 1483637. https://doi.org/10.1080/16549716.2018.1483637
   PubMed Web of Science ®Google Scholar
• Kariuki, S, C. Wairimu, and C. Mbae. 2021. “Antimicrobial Resistance in Endemic Enteric Infections in Kenya and the Region, and Efforts Toward Addressing the Challenges.” The Journal of Infectious Diseases 224 (12 Suppl 2): S883–S889. https://doi.org/10.1093/infdis/jiab457
   PubMedGoogle Scholar
• Khouja, T, K. Mitsantisuk, M. Tadrous, and K. J. Suda. 2022. “Global Consumption of Antimicrobials: Impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 Coronavirus Pandemic (COVID-19).” The Journal of Antimicrobial Chemotherapy 77 (5): 1491–1499. https://doi.org/10.1093/jac/dkac028
   PubMed Web of Science ®Google Scholar
• Krewski, D, M. E. Andersen, M. G. Tyshenko, K. Krishnan, T. Hartung, K. Boekelheide, J. F. Wambaugh, et al. 2020. “Toxicity Testing in the 21st Century: Progress in the Past Decade and Future Perspectives.” Archives of Toxicology 94 (1): 1–58. https://doi.org/10.1007/s00204-019-02613-4
   PubMed Web of Science ®Google Scholar
• Krewski, D, P. Saunders-Hastings, R. A. Baan, T. S. Barton-Maclaren, P. Browne, W. A. Chiu, M. Gwinn, et al. 2022a. “Development of an Evidence-Based Risk Assessment Framework.” ALTEX 39:667–693. https://doi.org/10.14573/altex.2004071
   PubMedGoogle Scholar
• Krewski, D, P. Saunders-Hastings, P. Larkin, M. Westphal, G. Tyshenko, M. Leiss, W. Dusseault, M. Jerrett, and M. D. Coyle. 2022b. “Principles of Risk Decision-Making.” Journal of Toxicology and Environmental Health - Part B 25 (5): 250–278. https://doi.org/10.1080/10937404.2022.2107591
   PubMed Web of Science ®Google Scholar
• Krewski, D, M. Westphal, M. E. Andersen, G. M. Paoli, W. A. Chiu, M. Al-Zoughool, M. C. Croteau, L. D. Burgoon, and I. Cote. 2014. “A Framework for the Next Generation of Risk Science.” Environmental Health Perspectives 122 (8): 796–805. https://doi.org/10.1289/ehp.1307260
   PubMed Web of Science ®Google Scholar
• Krishan, M, L. Navarro, B. Beck, R. Carvajal, and M. Dourson. 2021. “A Regulatory Relic: After 60 Years of Research on Cancer Risk, the Delaney Clause Continues to Keep Us in the Past.” Toxicology and Applied Pharmacology 433:115779. https://doi.org/10.1016/j.taap.2021.115779
   PubMed Web of Science ®Google Scholar
• Lam, C. W, M. P. Aguirre, K. Schischke, N. F. Nissen, O. A. Ogunseitan, and J. M. Schoenung. 2012. “International Harmonization of Models for Selecting Less Toxic Chemical Alternatives: Effect of Regulatory Disparities in the United States and Europe.” Integrated Environmental Assessment and Management 8 (4): 723–730. https://doi.org/10.1002/ieam.1305
   PubMed Web of Science ®Google Scholar
• Lammie, S. L, and J. M. Hughes. 2016. “Antimicrobial Resistance, Food Safety, and One Health: The Need for Convergence.” Annual Review of Food Science and Technology 7 (1): 287–312. https://doi.org/10.1146/annurev-food-041715-033251
   PubMedGoogle Scholar
• Lobie, T. A, A. A. Roba, J. A. Booth, K. I. Kristiansen, A. Aseffa, K. Skarstad, and M. Bjørås. 2021. “Antimicrobial Resistance: A Challenge Awaiting the Post-COVID-19 Era.” International Journal of Infectious Diseases 111:322–325. https://doi.org/10.1016/j.ijid.2021.09.003
   PubMed Web of Science ®Google Scholar
• Munkholm, L, and O. Rubin. 2020. “The Global Governance of Antimicrobial Resistance: A Cross-Country Study of Alignment Between the Global Action Plan and National Action Plans.” Globalization and Health 16 (1): 109. https://doi.org/10.1186/s12992-020-00639-3
   PubMed Web of Science ®Google Scholar
• Nunn, P, A. Harries, P. Godfrey-Faussett, R. Gupta, D. Maher, and M. Raviglione. 2002. “The Research Agenda for Improving Health Policy, Systems Performance, and Service Delivery for Tuberculosis Control: A WHO Perspective.” Bulletin of the World Health Organization 80 (6): 471–476. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567526/
   PubMed Web of Science ®Google Scholar
• Ogyu, A, O. Chan, J. Littmann, H. H. Pang, X. Lining, P. Liu, N. Matsunaga, N. Ohmagari, K. Fukuda, and D. Wernli. 2020. “National Action to Combat AMR: A One-Health Approach to Assess Policy Priorities in Action Plans.” BMJ Global Health 5 (7): e002427. https://doi.org/10.1136/bmjgh-2020-002427
   PubMed Web of Science ®Google Scholar
• Ohemu, G. P 2022. “Starved of ACTION: A Critical Look at the Antimicrobial Resistance Action Plans of African Countries.” ACS Infectious Disease 8 (8): 1377–1380. https://doi.org/10.1021/acsinfecdis.2c00303
   PubMed Web of Science ®Google Scholar
• Orubu, E. S. F, M. H. Zaman, M. T. Rahman, and V. J. Wirtz. 2020. “Veterinary Antimicrobial Resistance Containment in Bangladesh: Evaluating the National Action Plan and Scoping the Evidence on Implementation.” Journal of Global Antimicrobial Resistance 21:105–115. https://doi.org/10.1016/j.jgar.2019.09.020
   PubMed Web of Science ®Google Scholar
• O’Sullivan, T, and Y. Khan 2020. WHO Guidance on Research Methods for Health Emergency and Disaster Risk Management - Addressing Complexity Through Mixed Methods. https://apps.who.int/iris/bitstream/handle/10665/345591/9789240032286-eng.pdf
   Google Scholar
• Palinkas, L. A, G. A. Aarons, S. Horwitz, P. Chamberlain, M. Hurlburt, and J. Landsverk. 2011. “Mixed Method Designs in Implementation Research.” Administration and Policy in Mental Health and Mental Health Services Research 38 (1): 44–53. https://doi.org/10.1007/s10488-010-0314-z
   PubMed Web of Science ®Google Scholar
• Pallocca, G, M. J. Mone, H. Kamp, M. Luijten, B. Van de Water, and M. Leist. 2022. “Next-Generation Risk Assessment of Chemicals - Rolling Out a Human-Centric Testing Strategy to Drive 3R Implementation: The RISK-HUNT3R Project Perspective.” Altex-Alternativen Zu Tierexperimenten 39:419–426. https://doi.org/10.14573/altex.2204051
   PubMedGoogle Scholar
• Parish, S. T, M. Aschner, W. Casey, M. Corvaro, M. R. Embry, S. Fitzpatrick, D. Kidd, et al. 2020. “An Evaluation Framework for New Approach Methodologies (NAMs) for Human Health Safety Assessment.” Regulatory Toxicology and Pharmacology: RTP 112:104592. https://doi.org/10.1016/j.yrtph.2020.104592
   PubMed Web of Science ®Google Scholar
• Patton, M. Q 2002. Qualitative Research and Evaluation Methods. 3rd Edition ed. Thousand Oaks, California: SAGE Publications, Inc.
   Google Scholar
• Pawson, R 2017. An Introduction to Realist Evaluation London, Sage Research Methods.Accessed December 13, 2021. https://methods.sagepub.com/video/an-introduction-to-realist-evaluation
   Google Scholar
• Pawson, R, T. Greehalg, G. Harvey, and W. Kieran 2004. Realist Synthesis: An Introduction. https://www.betterevaluation.org/tools-resources/realist-synthesis-introduction
   Google Scholar
• Pawson, R, T. Greenhalgh, G. Harvey, and K. Washe. 2005. “Realist Review – a New Method of Systematic Review Designed for Complex Policy Interventions.” Journal of Health Services Research & Policy 10 (1_suppl): 21–34. https://doi.org/10.1258/1355819054308530
   PubMedGoogle Scholar
• Pawson, R, and N. Tilley. 2004. Realistic Evaluation. Community Matters: Resources. http://www.communitymatters.com.au/RE_chapter.pdf
   Google Scholar
• Pelfrene, E, R. Botgros, and M. Cavaleri. 2021. “Antimicrobial Multidrug Resistance in the Era of COVID-19: A Forgotten Plight?” Antimicrobial Resistance & Infection Control 10 (1): 21. https://doi.org/10.1186/s13756-021-00893-z
   PubMed Web of Science ®Google Scholar
• Pest Management Regulatory Agency. 2021. A Framework for Risk Assessment and Risk Management of Pest Control Products Health Canada. https://publications.gc.ca/collections/collection_2021/sc-hc/H114-41-2021-eng.pdf
   Google Scholar
• Peters, D. H 2014. “The Application of Systems Thinking in Health: Why Use Systems Thinking?” Health Research Policy & Systems / BioMed Central 12 (1). https://doi.org/10.1186/1478-4505-12-51
   Google Scholar
• Phelan, A. L, and L. O. Gostin. 2017. “Law as a Fixture Between the One Health Interfaces of Emerging Diseases.” Transactions of the Royal Society of Tropical Medicine and Hygiene 111 (6): 241–243. https://doi.org/10.1093/trstmh/trx044
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada. 2023. Pan-Canadian Action Plan on Antimicrobial Resistance. https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance/pan-canadian-action-plan-antimicrobial-resistance.pdf
   Google Scholar
• Ramon Pardo, P, H. Sati, and M. Galas. 2018. “Enfoque de Una Salud en las acciones para enfrentar la resistencia a los antimicrobianos desde una óptica latinoamericana.” Revista peruana de medicina experimental y salud publica 35 (1): 103–109. https://doi.org/10.17843/rpmesp.2018.351.3605
   PubMedGoogle Scholar
• Rogers, M. D 2003. “Risk Analysis Under Uncertainty, the Precautionary Principle, and the New EU Chemicals Strategy.” Regulatory Toxicology and Pharmacology: RTP 37 (3): 370–381. https://doi.org/10.1016/s0273-2300(03)00030-8
   PubMed Web of Science ®Google Scholar
• Sauer, U. G 2004a. “Avoidance of Animal Experiments in the New EU Chemicals Regulation - Opportunities and Problems from the Point of View of Animal Welfare.” ALTEX 21 (1): 9–14
   PubMedGoogle Scholar
• Sauer, U. G 2004b. “The New EU Chemicals Policy: Challenges and Chances for Animal-Free Test Methods.” Alternatives to Laboratory Animals: ATLA 32 (1_suppl): 343–348. https://doi.org/10.1177/026119290403201s56
   PubMedGoogle Scholar
• Sewell, F, D. Lewis, J. Mehta, C. Terry, and I. Kimber. 2021. “Rethinking Agrochemical Safety Assessment: A Perspective.” Regulatory Toxicology and Pharmacology: RTP 127:105068. https://doi.org/10.1016/j.yrtph.2021.105068
   PubMed Web of Science ®Google Scholar
• Shabangu, K, S. Y. Essack, and S. E. Duma. 2023. “Barriers to Implementing National Action Plans on Antimicrobial Resistance Using a One Health Approach: Policymakers’ Perspectives from South Africa and Eswatini.” Journal of Global Antimicrobial Resistance 33:130–136. https://doi.org/10.1016/j.jgar.2023.02.007
   PubMed Web of Science ®Google Scholar
• Sheffield, J, S. Sankaran, and T. Haslett. 2012. “Systems Thinking: Taming Complexity in Project Management.” On the Horizon 20 (2): 126–136. https://doi.org/10.1108/10748121211235787
   Google Scholar
• Silbergeld, E. K, D. Mandrioli, and C. F. Cranor. 2015. “Regulating Chemicals: Law, Science, and the Unbearable Burdens of Regulation.” Annual Review of Public Health 36 (1): 175–191. https://doi.org/10.1146/annurev-publhealth-031914-122654
   PubMedGoogle Scholar
• Simon, H 1997. Administrative Behavior: A Study of Decision-Making Processes in Administrative Organizations. Fourth Edition ed. New York, NY: The Free Press.
   Google Scholar
• Sparrow, M. K 2020. Fundamentals of Regulatory Design Paperback&kindle. North Haven, CT: Kindle Direct Publishing.
   Google Scholar
• Stucki, A. O, T. S. Barton-Maclaren, Y. Bhuller, J. E. Henriquez, T. R. Henry, C. Hirn, J. Miller-Holt, et al. 2022. “Use of New Approach Methodologies (NAMs) to Meet Regulatory Requirements for the Assessment of Industrial Chemicals and Pesticides for Effects on Human Health.” Frontiers in Toxicology 4:964553. https://doi.org/10.3389/ftox.2022.964553
   PubMedGoogle Scholar
• Sulis, G, M. Pai, and S. Gandra. 2022. “Comment On: Global Consumption of Antimicrobials: Impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 Coronavirus Pandemic (COVID-19).” The Journal of Antimicrobial Chemotherapy 77 (10): 2891–2892. https://doi.org/10.1093/jac/dkac180
   PubMed Web of Science ®Google Scholar
• Tamhankar, A. J, and V. Diwan. 2022. “Integrated Antimicrobial Resistance Management Strategy: A Way Forward to Mitigate Antimicrobial Resistance Crisis.” The Indian Journal of Medical Research 156 (4&5): 615–618. https://doi.org/10.4103/ijmr.ijmr_2444_21
   PubMed Web of Science ®Google Scholar
• Tannenbaum, L. V 2012. “Is NexGen Really the Next Generation of Risk Assessment?” Integrated Environmental Assessment and Management 8 (2): 213–214. https://doi.org/10.1002/ieam.1297
   PubMed Web of Science ®Google Scholar
• Tejpar, S, S. Rogers Van Katwyk, L. Wilson, and S. J. Hoffman. 2022. “Taking Stock of Global Commitments on Antimicrobial Resistance.” BMJ Global Health 7 (5): e008159. https://doi.org/10.1136/bmjgh-2021-008159
   PubMed Web of Science ®Google Scholar
• Trevisan, L 2011. “Human Health and the Environment Can't Wait for Reform: Current Opportunities for the Federal Government and States to Address Chemical Risks Under the Toxic Substances Control Act.” The American University Law Review 61 (2): 385–430
   PubMedGoogle Scholar
• Trochim, W. M. K 1989. “An Introduction to Concept Mapping for Planning and Evaluation.” Evaluation and Program Planning 12 (1): 1–16. https://doi.org/10.1016/0149-7189(89)90016-5
   Web of Science ®Google Scholar
• Trochim, W. M, D. A. Cabrera, B. Milstein, R. S. Gallagher, and S. J. Leischow. 2006. “Practical Challenges of Systems Thinking and Modeling in Public Health.” American Journal of Public Health 96 (3): 538–546. https://doi.org/10.2105/AJPH.2005.066001
   PubMed Web of Science ®Google Scholar
• van der Vegt, R. G, S. Maguire, D. Crump, M. Hecker, N. Basu, and G. M. Hickey. 2022. “Chemical Risk Governance: Exploring Stakeholder Participation in Canada, the USA, and the EU.” AMBIO: A Journal of the Human Environment 51 (7): 1698–1710. https://doi.org/10.1007/s13280-021-01671-2
   Google Scholar
• van der Zalm, A. J, J. Barroso, P. Browne, W. Casey, J. Gordon, T. R. Henry, N. C. Kleinstreuer, A. B. Lowit, M. Perron, and A. J. Clippinger. 2022. “A Framework for Establishing Scientific Confidence in New Approach Methodologies.” Archives of Toxicology 96 (11): 2865–2879. https://doi.org/10.1007/s00204-022-03365-4
   PubMed Web of Science ®Google Scholar
• Vindrola-Padros, C, T. Pape, M. Utley, and N. J. Fulop. 2017. “The Role of Embedded Research in Quality Improvement: A Narrative Review.” BMJ Quality & Safety 26 (1): 70–80. https://doi.org/10.1136/bmjqs-2015-004877
   PubMed Web of Science ®Google Scholar
• Wang, X, Z. Lin, and J. Lu. 2018. “One Health Strategy to Prevent and Control Antibiotic Resistance.” Sheng Wu Gong Cheng Xue Bao 34 (8): 1361–1367. https://doi.org/10.13345/j.cjb.180249
   PubMedGoogle Scholar
• Willemsen, A, S. Reid, and Y. Assefa. 2022. “A Review of National Action Plans on Antimicrobial Resistance: Strengths and Weaknesses.” Antimicrobial Resistance & Infection Control 11 (1): 90. https://doi.org/10.1186/s13756-022-01130-x
   PubMed Web of Science ®Google Scholar
• Wolf, D. C, Y. Bhuller, R. Cope, M. Corvaro, R. Currie, J. Doe, A. Doi, et al. 2022. “Transforming the Evaluation of Agrochemicals.” Pest Management Science 78 (12): 5049–5056. https://doi.org/10.1002/ps.7148
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2015. Global Action Plan on Antimicrobial Resistance. https://www.who.int/publications/i/item/9789241509763
   Google Scholar
• World Health Organization. 2019. Turning Plans into Action for Antimicrobial Resistance (AMR). Working Paper 2.0: Implementation and Coordination. https://www.who.int/publications/i/item/turning-plans-into-action-for-antimicrobial-resistance-(-amr)-working-paper-2.0-implementation-and-coordination
   Google Scholar
• World Health Organization. 2023. Global Research Agenda for Antimicrobial Resistance in Human Health - Policy Brief. https://www.who.int/publications/m/item/global-research-agenda-for-antimicrobial-resistance-in-human-health
   Google Scholar
• Zuang, V, E. P. Daskalopoulos. 2023. Non-Animal Methods in Science and Regulation – EURL ECVAM Status Report 2022. Publications Office of the European Union, Luxembourg. https://op.europa.eu/en/publication-detail/-/publication/71ab691d-c9f6-11ed-a05c-01aa75ed71a1/language-en
   Google Scholar